News

Novel validation and experimentation services for SMEs for AI and robotics-based healthcare solutions

Published on | 2 weeks ago

Programmes
Health EIT AI Continent

The Testing and Experimentation Facility for Health AI and Robotics (TEF-Health) has opened a call offering SMEs discounted access to novel validation and experimentation services for health AI and robotic solutions. Through TEF-Health, SMEs can work with European research centres, hospitals, universities and certification bodies to test AI and robotics solutions using high-quality data and real clinical environments, helping prepare products for market entry.

More information on the call and its requirements can be found on the dedicated website.

The call stays open until the capacity of the service providers is reached, and closes at the latest at the end of the TEF-Health project funding period on 31 December 2027.

Background: TEF-Health is a Digital Europe project coordinated by Charité Universitätsmedizin Berlin, Germany and comprises 52 partners from 9 European Union countries — each forming a so-called Node. The project is co-financed by national funding provided by Belgium, France, Germany, Portugal, Slovakia and Sweden.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1983 articles available search in articles 

Testimonial

image of ONELAB: City of Hasselt contribute to development of Rapid Response Mobile Labs

ONELAB: City of Hasselt contribute to development of Rapid Response Mobile Labs

The City of Hasselt took part in the ONELAB project (2022–2025) as an end user. The project was funded under Horizon Europe (HORIZON-CL3-2021-DRS-01-05) and focused on developing modular Rapid Response Mobile Laboratories (RRML). These laboratories are designed for rapid deployment in a variety of settings to support disease monitoring.